The effectiveness of Apigenin derivatives has been utilized in this current investigation as the proposed compounds for the novel treatments for HPV-associated cervical cancer and the DNA polymerase theta since there is no targeted therapy for them. Here, POLQ is linked to cervical carcinoma.